| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Antiviral efficacy against influenza virus and pharmacokinetic analysis of a novel MEK-inhibitor, ATR-002, in cell culture and in the mouse model
|
Laure, Martin
|
|
|
178 |
C |
p.
|
article
|
| 2 |
Coronavirus membrane fusion mechanism offers a potential target for antiviral development
|
Tang, Tiffany
|
|
|
178 |
C |
p.
|
article
|
| 3 |
DDX3 inhibitors show antiviral activity against positive-sense single-stranded RNA viruses but not against negative-sense single-stranded RNA viruses: The coxsackie B model
|
Quaranta, Paola
|
|
|
178 |
C |
p.
|
article
|
| 4 |
Design of TLR2-ligand-synthetic long peptide conjugates for therapeutic vaccination of chronic HBV patients
|
Dou, Yingying
|
|
|
178 |
C |
p.
|
article
|
| 5 |
Editorial Board
|
|
|
|
178 |
C |
p.
|
article
|
| 6 |
Effect of antiviral treatment in older patients hospitalized with confirmed influenza
|
Soldevila, Núria
|
|
|
178 |
C |
p.
|
article
|
| 7 |
Glibenclamide inhibits BK polyomavirus infection in kidney cells through CFTR blockade
|
Panou, Margarita-Maria
|
|
|
178 |
C |
p.
|
article
|
| 8 |
In vitro and in vivo growth inhibition of human cervical cancer cells via human papillomavirus E6/E7 mRNAs’ cleavage by CRISPR/Cas13a system
|
Chen, Yili
|
|
|
178 |
C |
p.
|
article
|
| 9 |
Ivermectin and COVID-19: A report in Antiviral Research, widespread interest, an FDA warning, two letters to the editor and the authors' responses
|
Bray, Mike
|
|
|
178 |
C |
p.
|
article
|
| 10 |
Low replicative fitness of neuraminidase inhibitor-resistant H7N9 avian influenza a virus with R292K substitution in neuraminidase in cynomolgus macaques compared with I222T substitution
|
Suzuki, Saori
|
|
|
178 |
C |
p.
|
article
|
| 11 |
p53 and p53-related mediators PAI-1 and IGFBP-3 are downregulated in peripheral blood mononuclear cells of HIV-patients exposed to non-nucleoside reverse transcriptase inhibitors
|
Gruevska, Aleksandra
|
|
|
178 |
C |
p.
|
article
|
| 12 |
Put a cork in it: Plugging the M2 viral ion channel to sink influenza
|
Jalily, Pouria H.
|
|
|
178 |
C |
p.
|
article
|
| 13 |
Remdesivir and SARS-CoV-2: Structural requirements at both nsp12 RdRp and nsp14 Exonuclease active-sites
|
Shannon, Ashleigh
|
|
|
178 |
C |
p.
|
article
|
| 14 |
Remdesivir, lopinavir, emetine, and homoharringtonine inhibit SARS-CoV-2 replication in vitro
|
Choy, Ka-Tim
|
|
|
178 |
C |
p.
|
article
|
| 15 |
Synthesis and antiviral effect of novel fluoxetine analogues as enterovirus 2C inhibitors
|
Manganaro, Roberto
|
|
|
178 |
C |
p.
|
article
|
| 16 |
The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro
|
Caly, Leon
|
|
|
178 |
C |
p.
|
article
|
| 17 |
The trimeric artesunate derivative TF27 exerts strong anti-cytomegaloviral efficacy: Focus on prophylactic efficacy and oral treatment of immunocompetent mice
|
Wild, Markus
|
|
|
178 |
C |
p.
|
article
|
| 18 |
Type 1 interferons as a potential treatment against COVID-19
|
Sallard, Erwan
|
|
|
178 |
C |
p.
|
article
|
Journal description